VEGFA and glioblastoma: The first one encodes for a growth factor which is a major regulator of angiogenesis and adaptation to hypoxia, the second encodes for an endothelial cell marker associated with the infiltrative growth of GBM tumor promoted by the anti-VEGF monoclonal antibody bevacizumab [38].